ClinicalTrials.gg
CompletedNCT00737828Updated May 21, 2014

Cardiopulmonary Exercise Testing and Preoperative Risk Stratification

An interventional study of Perioperative care pathway guided by CPX results in Colorectal Cancer, Anaesthesia and Critical Illness, sponsored by University College London Hospitals. Completed at 3 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-05-21.

Sponsored by University College London Hospitals · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
228
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators would like to evaluate the use of cardiopulmonary exercise tests (CPX) in guiding the care pathway of patients undergoing colorectal operations. In the intervention group care will be guided by CPX results and in the control group care will be guided by the doctors assessment. The investigators would like to assess the impact of this on patient outcome, patient satisfaction and resource usage.

Read the detailed description

Each year 20000 UK patients die within 30 days of surgery. It seems that in the UK a patient's chances of becoming seriously unwell or dying following surgery is higher than in comparable countries. Fewer beds in the UK are given over to Intensive Care than in these other countries. Closer attention to the care given after operations, which can be achieved on intensive care units (ICU), almost certainly reduces the chances of serious illness following major surgery. An increase in the number of intensive care unit beds in the UK is extremely unlikely. Better use of the available intensive care beds could be achieved by allocating them where they are believed to improve outcome (following surgery) and by allocating them to patients most likely to benefit.

Tests used to assess risk of surgery to patients are largely ineffective. Cardiopulmonary exercise tests (CPX) seem to be effective at identifying patients at risk of death or serious illness post surgery. This information has been used in studies to select patients for ICU beds and reduce deaths. The studies so far have limitations in their design and scope which means we can't be certain this approach works in the UK.

We suggest a study to answer this question more conclusively and more specifically in UK patients. We will randomly divide patients between two groups. In the 1st group choice of postoperative care environment is based on best current practice and in the other group we will make these decisions (critical care or ward) based on the results of the CPX.

We hope that the benefits will include less patients becoming seriously ill or dying and shorter stays in hospital after surgery following major operations. We also hope the information will help patients understand the risks of their operation better and therefore make better informed decisions. This may also reduce the overall cost of surgery for hospitals.

02

Conditions studied

  • Colorectal Cancer
  • Anaesthesia
  • Critical Illness

Keywords

  • Cardiopulmonary exercise test
  • CPX
  • CPEX
  • surgical outcome
  • colorectal surgery
  • risk stratification
03

In context

Colorectal Neoplasms

5,734 studies on the registry are indexed under Colorectal Neoplasms; 1,481 are open to participants now.

This study's enrollment of 228 is above the median of 77 across 4,222 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

University College London Hospitals is the lead sponsor of 63 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults ≥ 18 years age
  2. Males
  3. Females
  4. Listed for elective(non-emergency) colorectal surgery

Exclusion criteria

Exclusion Criteria:

  1. Age \< 18 years age
  2. Patient unwilling/unable to consent
  3. Adults with learning disabilities or dementia
  4. Prisoners
  5. Any contraindication to cardiopulmonary exercise testing (as outlined by *American Association of Anaesthesia:

    • Acute MI (3-5 days)
    • Unstable angina
    • Uncontrolled arrhythmias
    • Syncope
    • Acute endocarditis
    • Acute myocarditis
    • Acute pericarditis
    • Symptomatic severe aortic stenosis
    • Uncontrolled heart failure
    • Acute pulmonary embolism or infarction
    • Thrombosis of lower extremities
    • Dissecting aneurysm
    • Uncontrolled asthma
    • Pulmonary oedema
    • Room air desaturation at rest \<85%
    • Respiratory failure
    • Acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise Mental impairment leading to inability to co-operate
  6. Patients already enrolled in an interventional study
  7. Previous CPX test result recorded in the medical notes
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
228 participants (actual)

Study arms

  • Active comparator
    A

    Control - Standard Perioperative Pathway, clinician decides post-operative care environment (usual care)

    Other: Perioperative care pathway guided by CPX results

  • Experimental
    B

    Intervention - Perioperative care pathway guided by CPX Results i.e.anaerobic threshold \& ventilatory equivalents

    Other: Perioperative care pathway guided by CPX results

Interventions

  • OtherPerioperative care pathway guided by CPX results

    * AT \> 11ml/min/kg no myocardial ischaemia or Ve/VO2 \<35 - Level 1 Ward Care * AT \> 11ml/min/kg with myocardial ischaemia or Ve/VO2 \>35 - Level 2/3 (ITU) Critical Care Unit * AT \<11mls/min/kg - Level 2/3 Critical Care Unit * AT \<8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure

06

What researchers measure

Primary outcomes

  1. Postoperative morbidity (presence or absence of POMS defined morbidity)

    Time frame: Day 5

Secondary outcomes

  1. Post operative morbidity domains e.g. gastrointestinal, renal, pulmonary

    Time frame: Day 5

  2. Total postoperative ITU bed utilisation

    Time frame: End of hospital stay i.e. day of hospital discharge

  3. Total postoperative bed utilisation

    Time frame: End of hospital stay i.e. day of hospital discharge

  4. ITU re-admission

    Time frame: End of hospital stay i.e. day of hospital discharge

  5. Death

    Time frame: Should death occur

  6. SF36 (compared with SF36 at baseline)

    Time frame: 12 months post day of surgery

07

Study locations

3 sites
  • Whittington Hospital NHS Trust
    London, N19 5NF, United Kingdom
  • University College London Hospitals NHS Foundation Trust
    London, NW1 2BU, United Kingdom
  • Southampton University Hospitals NHS Trust
    Southampton, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 21, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00737828
Lead sponsor
University College London Hospitals
Responsible party
Mike Grocott (Professor, University College London Hospitals) — Principal investigator
First posted
Aug 20, 2008
Start date
Aug 2008
Primary completion
Jun 2013
Completion
May 2014
Last update
May 21, 2014

Study contacts

Michael PW Grocott
study director · University College, London
Paula Meale
principal investigator · University College, London
Michael Mythen
principal investigator · University College, London
Ayo Oshowo
principal investigator · Whittington Hospital NHS Trust
Mervyn Singer
principal investigator · University College, London
Geoff Bellingan
principal investigator · University College London Hospitals
Kay Mitchell
principal investigator · University College, London
Hasan Muktar
principal investigator · The Whittington Hospital Hospital NHS Trust
Alistair Windsor
principal investigator · University College London Hospitals
Jim Down
principal investigator · University College London Hospitals
Martin B Kuper
principal investigator · Whittington Hospital NHS Trust
Denny ZH Levett
principal investigator · University College, London
Phil Hennis, PhD
principal investigator · UCL
Alasdair O'Doherty, MSc
principal investigator · UCL
Alec Engledow
principal investigator · University College London Hospitals
Aundrea Mulreany
principal investigator · Whittington Hospital
Carolyn Dr Way
principal investigator · University Hospital Southampton NHS Foundation Trust
Karen Linford
principal investigator · University Hospital Southampton NHS Foundation Trust
Clare Bolger
principal investigator · University Hospital Southampton NHS Foundation Trust
Paul Nichols
principal investigator · University Hospital Southampton NHS Foundation Trust
Kim Golder
principal investigator · University Hospital Southampton NHS Foundation Trust
John S Knight
principal investigator · University Hospital Southampton NHS Foundation Trust
Michael Celinski
principal investigator · University Hospital Southampton NHS Foundation Trust
Grace Adesina
principal investigator · University College London Hospitals

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion